Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients — Stella

Recruiting

Back to Neuromuscular Blockade trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Korea

Seoul National University Hospital, Seoul, Jongno-gu

Key details

Sponsor

Seoul National University Hospital

Enrollment target

~30 participants

Started

January 2024

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 90 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov